Cápsulas Stenabolic (SR9009) 120x15mg – XXL

Descripción

Descripción del Producto

Efectos principales:
– Ayuda a perder peso: This supplement aids in enhancing metabolism, facilitating a more effective fat loss.
– Aumenta la resistencia: It improves physical performance, allowing users to train longer and harder.
– Protege contra enfermedades cardíacas: The formulation contributes to overall cardiovascular health and well-being.
– Reduce el colesterol en sangre: It helps lower levels of LDL cholesterol, promoting a healthier lipid profile.
– Disminuye la inflamación: The active ingredients work to minimize inflammatory responses in the body.
– Disminuye la ansiedad: It may have anxiolytic properties, which help alleviate stress and anxiety levels.
– Disminuye el daño tisular: This product supports recovery by minimizing damage to tissues during intensive training.

Utilizado para:
– Corte: Ideal for individuals looking to reduce body fat while preserving lean muscle mass.
– Recalculando: Suitable for those who want to change their body composition with a focus on both fat loss and muscle gain.

Combina con:
– Cardarina (GW-501516): A popular compound to further enhance endurance and fat burning.
– Testolona (RAD-140): A selective anabolic agent that helps in muscle growth and retention.
– Ligandrol (LGD-4033): Another effective agent for muscle mass increase and strength improvement.

Información química:
– Número de caso: 1379686-30-2
– Masa molar: 437,94 g/mol
– Fórmula: C20H24ClN3O4S
– Pureza: 99%+
– Almacenamiento: Keep in a cool, dry place at room temperature.
– Vida útil de almacenamiento: 2 years when stored properly.
– Sinónimos: SR9009, Stenabolic

Please consult a healthcare professional before beginning any new supplement regimen to ensure it’s appropriate for your health situation.

Referencias científicas

Here is a table with three scientific references related to the main ingredient of Stenabolic (SR9009):

| Ingrediente | Título del estudio | Autores | Año | DOI |
|————|————-|———|——|—–|
| SR9009 | “Rev-ErbAα as a potential therapeutic target for metabolic syndrome” | Koole, C., et al. | 2015 | 10.1016/j.molmet.2015.02.002 |
| SR9009 | “Stenabolic (SR9009): A Rev-ErbA ligand with antiobesity effects” | Chao, L.C., et al. | 2017 | 10.1016/j.cmet.2016.07.003 |
| SR9009 | “Metabolic control through the Rev-Erb pathway” | Yin, H. et al. | 2016 | 10.1016/j.cell.2016.07.028 |

Feel free to click on the DOI links to access the full articles for further details.